Literature DB >> 21049974

Synthesis of essramycin and comparison of its antibacterial activity.

Ernest H L Tee1, Tomislav Karoli, Soumya Ramu, Johnny X Huang, Mark S Butler, Matthew A Cooper.   

Abstract

The triazolopyrimidine natural product essramycin (1) was synthesized without the use of protecting groups via a two-step reaction scheme involving a 3-amino-1,2,4-triazole intermediate, and its structure was unequivocally determined. However, in contrast to the natural product, the synthetic essramycin (1) did not display any antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21049974     DOI: 10.1021/np100648q

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

Review 1.  1,2,4-Triazolo[1,5-a]pyrimidines in drug design.

Authors:  Killian Oukoloff; Bobby Lucero; Karol R Francisco; Kurt R Brunden; Carlo Ballatore
Journal:  Eur J Med Chem       Date:  2019-01-14       Impact factor: 6.514

2.  The Natural Product Essramycin and Three of Its Isomers Are Devoid of Antibacterial Activity.

Authors:  Huan Wang; Dusan Hesek; Mijoon Lee; Elena Lastochkin; Allen G Oliver; Mayland Chang; Shahriar Mobashery
Journal:  J Nat Prod       Date:  2016-04-06       Impact factor: 4.050

3.  Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation.

Authors:  Maria P Ikonomopoulou; Manuel A Fernandez-Rojo; Sandy S Pineda; Pablo Cabezas-Sainz; Brit Winnen; Rodrigo A V Morales; Andreas Brust; Laura Sánchez; Paul F Alewood; Grant A Ramm; John J Miles; Glenn F King
Journal:  Sci Rep       Date:  2018-08-01       Impact factor: 4.379

4.  Retracted Article: The synthesis and biological activity of marine alkaloid derivatives and analogues.

Authors:  Shiyang Zhou; Gangliang Huang
Journal:  RSC Adv       Date:  2020-08-28       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.